Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer's Disease
Copyright © 2020 Brem, Di Iorio, Fried, Oliveira-Maia, Marra, Profice, Quaranta, Schilberg, Atkinson, Seligson, Rossini and Pascual-Leone..
OBJECTIVE: To investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training for treatment of cognitive symptoms in patients with Alzheimer's disease (AD). A secondary objective was to analyze associations between brain plasticity and cognitive effects of treatment.
METHODS: In this randomized, sham-controlled, multicenter clinical trial, 34 patients with AD were assigned to three experimental groups receiving 30 daily sessions of combinatory intervention. Participants in the real/real group (n = 16) received 10 Hz repetitive transcranial magnetic stimulation (rTMS) delivered separately to each of six cortical regions, interleaved with computerized cognitive training. Participants in the sham rTMS group (n = 18) received sham rTMS combined with either real (sham/real group, n = 10) or sham (sham/sham group, n = 8) cognitive training. Effects of treatment on neuropsychological (primary outcome) and neurophysiological function were compared between the 3 treatment groups. These, as well as imaging measures of brain atrophy, were compared at baseline to 14 healthy controls (HC).
RESULTS: At baseline, patients with AD had worse cognition, cerebral atrophy, and TMS measures of cortico-motor reactivity, excitability, and plasticity than HC. The real/real group showed significant cognitive improvement compared to the sham/sham, but not the real/sham group. TMS-induced plasticity at baseline was predictive of post-intervention changes in cognition, and was modified across treatment, in association with changes of cognition.
INTERPRETATION: Combined rTMS and cognitive training may improve the cognitive status of AD patients, with TMS-induced cortical plasticity at baseline serving as predictor of therapeutic outcome for this intervention, and potential mechanism of action.
CLINICAL TRIAL REGISTRATION: www.ClinicalTrials.gov, identifier NCT01504958.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Frontiers in aging neuroscience - 12(2020) vom: 04., Seite 200 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Brem, Anna-Katharine [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alzheimer’s disease |
---|
Anmerkungen: |
Date Revised 15.04.2022 published: Electronic-eCollection ClinicalTrials.gov: NCT01504958 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fnagi.2020.00200 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313087539 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313087539 | ||
003 | DE-627 | ||
005 | 20231225145821.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fnagi.2020.00200 |2 doi | |
028 | 5 | 2 | |a pubmed24n1043.xml |
035 | |a (DE-627)NLM313087539 | ||
035 | |a (NLM)32733232 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Brem, Anna-Katharine |e verfasserin |4 aut | |
245 | 1 | 0 | |a Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer's Disease |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 15.04.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a ClinicalTrials.gov: NCT01504958 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2020 Brem, Di Iorio, Fried, Oliveira-Maia, Marra, Profice, Quaranta, Schilberg, Atkinson, Seligson, Rossini and Pascual-Leone. | ||
520 | |a OBJECTIVE: To investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training for treatment of cognitive symptoms in patients with Alzheimer's disease (AD). A secondary objective was to analyze associations between brain plasticity and cognitive effects of treatment | ||
520 | |a METHODS: In this randomized, sham-controlled, multicenter clinical trial, 34 patients with AD were assigned to three experimental groups receiving 30 daily sessions of combinatory intervention. Participants in the real/real group (n = 16) received 10 Hz repetitive transcranial magnetic stimulation (rTMS) delivered separately to each of six cortical regions, interleaved with computerized cognitive training. Participants in the sham rTMS group (n = 18) received sham rTMS combined with either real (sham/real group, n = 10) or sham (sham/sham group, n = 8) cognitive training. Effects of treatment on neuropsychological (primary outcome) and neurophysiological function were compared between the 3 treatment groups. These, as well as imaging measures of brain atrophy, were compared at baseline to 14 healthy controls (HC) | ||
520 | |a RESULTS: At baseline, patients with AD had worse cognition, cerebral atrophy, and TMS measures of cortico-motor reactivity, excitability, and plasticity than HC. The real/real group showed significant cognitive improvement compared to the sham/sham, but not the real/sham group. TMS-induced plasticity at baseline was predictive of post-intervention changes in cognition, and was modified across treatment, in association with changes of cognition | ||
520 | |a INTERPRETATION: Combined rTMS and cognitive training may improve the cognitive status of AD patients, with TMS-induced cortical plasticity at baseline serving as predictor of therapeutic outcome for this intervention, and potential mechanism of action | ||
520 | |a CLINICAL TRIAL REGISTRATION: www.ClinicalTrials.gov, identifier NCT01504958 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Alzheimer’s disease | |
650 | 4 | |a clinical trial | |
650 | 4 | |a cognitive training | |
650 | 4 | |a combinatory intervention | |
650 | 4 | |a plasticity | |
650 | 4 | |a randomized controlled | |
650 | 4 | |a transcranial magnetic stimulation | |
700 | 1 | |a Di Iorio, Riccardo |e verfasserin |4 aut | |
700 | 1 | |a Fried, Peter J |e verfasserin |4 aut | |
700 | 1 | |a Oliveira-Maia, Albino J |e verfasserin |4 aut | |
700 | 1 | |a Marra, Camillo |e verfasserin |4 aut | |
700 | 1 | |a Profice, Paolo |e verfasserin |4 aut | |
700 | 1 | |a Quaranta, Davide |e verfasserin |4 aut | |
700 | 1 | |a Schilberg, Lukas |e verfasserin |4 aut | |
700 | 1 | |a Atkinson, Natasha J |e verfasserin |4 aut | |
700 | 1 | |a Seligson, Erica E |e verfasserin |4 aut | |
700 | 1 | |a Rossini, Paolo Maria |e verfasserin |4 aut | |
700 | 1 | |a Pascual-Leone, Alvaro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in aging neuroscience |d 2009 |g 12(2020) vom: 04., Seite 200 |w (DE-627)NLM198856024 |x 1663-4365 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2020 |g day:04 |g pages:200 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fnagi.2020.00200 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2020 |b 04 |h 200 |